Van Dijck, Evelien
Van Laere, Steven
Logie, Emilie
Timmermans, Steven
Fransen, Erik
Ibrahim, Joe
Kendall, Timothy J.
Fallowfield, Jonathan A.
Mateiu, Ligia M.
Libert, Claude
Van Camp, Guy
Verrijken, An
Van Gaal, Luc
Francque, Sven
Van Hul, Wim
Berghe, Wim Vanden
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (11E6921N)
Fonds Wetenschappelijk Onderzoek (G1179120N)
Fonds Wetenschappelijk Onderzoek (1802154N)
Geconcerteerde Onderzoeksactie (FFB180348)
Geconcerteerde Onderzoeksactie (FFB180348)
Geconcerteerde Onderzoeksactie (FFB180348)
Geconcerteerde Onderzoeksactie (FFB180348)
Innovate UK (TS/R017581/1)
Innovate UK (TS/R017581/1)
Methusalem OEC grant - "GENOMED" (FFB190208)
RESOLVE (FP7-305707)
RESOLVE (FP7-305707)
European Commission projects HEPADIP (LSHM-CT-2005-018734)
European Commission projects HEPADIP (LSHM-CT-2005-018734)
Article History
Received: 8 May 2025
Accepted: 21 July 2025
First Online: 4 August 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Antwerp University Hospital (references A04-21 and 6/25/125, Belgian registration number B30020071389, date of approval: 21 October 2019). Informed consent was obtained for all involved patients. Approvals for the SteatoSITE database were provided by the West of Scotland Research Ethics Committee 4 (Reference: 20/WS/0002; 18 February 2020), Public Benefit and Privacy Panel for Health and Social Care (PBPP; Reference: 1819-0091; 4 June 2021), Institutional Research & Development departments and Caldicott Guardians.
: Not applicable.
: The authors declare no competing interests.